The European Society for Medical Oncology (ESMO) announced the professionals selected for its 2026 Fellowship Programme, including Maria Vieito and…
UITM-CaixaResearch
Researchers at VHIO have published an article in the journal European Journal of Cancer on the evolution of targeted therapies…
Pharmaceutical company Gilead held the award ceremony for the 11th and 12th editions of the Gilead Biomedical Research Grants this…
International Clinical Trials Day is celebrated on May 20 to raise awareness about the fundamental role of biomedical research in…
On April 28, Casa Milà – La Pedrera hosted the second session of the VHIOTalks 2026 series, titled “Innovation in…
From April 17 to 22, the American Association for Cancer Research (AACR) Annual Meeting was held in San Diego. Researchers…
After more than a decade of research, a new-generation CAR-T therapy developed by VHIO, in collaboration with the Hospital del…
Sponsored by F. Hoffmann-La Roche Ltd, in collaboration with Vall d’Hebron Institute of Oncology (VHIO), a first-in-human clinical trial was…
VHIO played a prominent role at the ESMO Targeted Anticancer Therapies (TAT) congress, one of the leading international forums in…
Reported at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany, results from four multicenter early phase…
